BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18593771)

  • 1. Reduced pancreatic volume in hepatocyte nuclear factor 1A-maturity-onset diabetes of the young.
    Vesterhus M; Haldorsen IS; Raeder H; Molven A; Njølstad PR
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3505-9. PubMed ID: 18593771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic exocrine dysfunction in maturity-onset diabetes of the young type 3.
    Vesterhus M; Raeder H; Johansson S; Molven A; Njølstad PR
    Diabetes Care; 2008 Feb; 31(2):306-10. PubMed ID: 17989309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exocrine pancreatic function in hepatocyte nuclear factor 1β-maturity-onset diabetes of the young (HNF1B-MODY) is only moderately reduced: compensatory hypersecretion from a hypoplastic pancreas.
    Tjora E; Wathle G; Erchinger F; Engjom T; Molven A; Aksnes L; Haldorsen IS; Dimcevski G; Raeder H; Njølstad PR
    Diabet Med; 2013 Aug; 30(8):946-55. PubMed ID: 23600988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
    Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
    Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intima-media thickness and endothelial dysfunction in GCK and HNF1A-MODY patients.
    Szopa M; Osmenda G; Wilk G; Matejko B; Skupien J; Zapala B; Młynarski W; Guzik T; Malecki MT
    Eur J Endocrinol; 2015 Mar; 172(3):277-83. PubMed ID: 25501962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study).
    Eide SA; Raeder H; Johansson S; Midthjell K; Søvik O; Njølstad PR; Molven A
    Diabet Med; 2008 Jul; 25(7):775-81. PubMed ID: 18513305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of pancreatic body and tail in HNF1B mutation carriers.
    Haldorsen IS; Vesterhus M; Raeder H; Jensen DK; Søvik O; Molven A; Njølstad PR
    Diabet Med; 2008 Jul; 25(7):782-7. PubMed ID: 18644064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series.
    Haddouche A; Bellanne-Chantelot C; Rod A; Fournier L; Chiche L; Gautier JF; Timsit J; Laboureau S; Chaillous L; Valero R; Larger E; Jeandidier N; Wilhelm JM; Popelier M; Guillausseau PJ; Thivolet C; Lecomte P; Benhamou PY; Reznik Y
    J Diabetes; 2020 Jan; 12(1):48-57. PubMed ID: 31166087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus.
    Nowak N; Hohendorff J; Solecka I; Szopa M; Skupien J; Kiec-Wilk B; Mlynarski W; Malecki MT
    Endocrine; 2015 Dec; 50(3):643-9. PubMed ID: 25987348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HNF1A mutant Ala180Val: Clinical challenges in determining causality of a rare HNF1A variant in familial diabetes.
    Sagen JV; Bjørkhaug L; Haukanes BI; Grevle L; Molnes J; Nedrebø BG; Søvik O; Njølstad PR; Johansson S; Molven A
    Diabetes Res Clin Pract; 2017 Nov; 133():142-149. PubMed ID: 28934671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel variants in the hepatocyte nuclear factor-1alpha gene in South Indian patients with maturity onset diabetes of young.
    Radha V; Ek J; Anuradha S; Hansen T; Pedersen O; Mohan V
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1959-65. PubMed ID: 19336507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing.
    López-Garrido MP; Herranz-Antolín S; Alija-Merillas MJ; Giralt P; Escribano J
    Clin Endocrinol (Oxf); 2013 Sep; 79(3):342-7. PubMed ID: 23009393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic volume and endocrine and exocrine functions in patients with diabetes.
    Philippe MF; Benabadji S; Barbot-Trystram L; Vadrot D; Boitard C; Larger E
    Pancreas; 2011 Apr; 40(3):359-63. PubMed ID: 21283038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
    Ellard S; Colclough K
    Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating CD36 is reduced in HNF1A-MODY carriers.
    Bacon S; Kyithar MP; Schmid J; Costa Pozza A; Handberg A; Byrne MM
    PLoS One; 2013; 8(9):e74577. PubMed ID: 24069322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function studies of HNF1A (MODY3) gene mutations in South Indian patients with monogenic diabetes.
    Balamurugan K; Bjørkhaug L; Mahajan S; Kanthimathi S; Njølstad PR; Srinivasan N; Mohan V; Radha V
    Clin Genet; 2016 Dec; 90(6):486-495. PubMed ID: 26853433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Analyses of HNF1A-MODY Variants Refine the Interpretation of Identified Sequence Variants.
    Malikova J; Kaci A; Dusatkova P; Aukrust I; Torsvik J; Vesela K; Kankova PD; Njølstad PR; Pruhova S; Bjørkhaug L
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32017842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes.
    Harries LW; Ellard S; Stride A; Morgan NG; Hattersley AT
    Hum Mol Genet; 2006 Jul; 15(14):2216-24. PubMed ID: 16760222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of HNF1A gene mutations in Greek patients with MODY3: relative frequency and identification of seven novel germline mutations.
    Tatsi C; Kanaka-Gantenbein C; Vazeou-Gerassimidi A; Chrysis D; Delis D; Tentolouris N; Dacou-Voutetakis C; Chrousos GP; Sertedaki A
    Pediatr Diabetes; 2013 Nov; 14(7):526-34. PubMed ID: 23517481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?
    Karlsson E; Shaat N; Groop L
    Diabet Med; 2008 Jul; 25(7):788-91. PubMed ID: 18513302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.